Trospium

• Analgesics
• ATC:G04BD09

• Sanctura
• Trospium Chloride
• Trospium Spiroalcohol

• No information avaliable

C₂₅H₃₀NO₃

http://www.rxlist.com/cgi/generic3/sanctura.htm

Trospium FDA

No information avaliable

392.511 g/mol

No information avaliable

No information avaliable

Solid

No information avaliable

Tablet

For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, Detrusor instability and frequency of micturition

Trospium is an antispasmodic, antimuscarinic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Receptor assays showed that trospium chloride has negligible affinity for nicotinic receptors as compared to muscarinic receptors at concentrations obtained from therapeutic doses.

9.6%

No information avaliable

Patients should be informed that anticholinergic agents, such as Sanctura, may produce clinically significant adverse effects related to anticholinergic pharmacological activity. For example, heat prostration (fever and heat stroke due to decreased sweating) can occur when anticholinergics such as Sanctura are used in a hot environment. Because anticholinergics such as Sanctura may also produce dizziness or blurred vision, patients should be advised to exercise caution. Patients should be informed that alcohol may enhance the drowsiness caused by anticholinergic agents.

Sanctura should be taken 1 hour prior to meals or on an empty stomach. If a dose is skipped, patients are advised to take their next dose 1 hour prior to their next meal.

Humans and other mammals